fig3

Figure 3. Fifty-five years of Australian newborn bloodspot screening^[2]. This figure shows the evolution of technology and conditions screened within Australian NBS programs and key governance milestones pertaining to the stewardship of NBS programs. *Timing of the introduction of conditions screened varied between states and territories of Australia; the earliest date is indicated. RACP: Royal Australasian College of Physicians; HGSA: Human Genetics Society of Australasia; NBS: newborn bloodspot screening; NSAPRD: National Strategic Action Plan for Rare Diseases; MRFF: Medical Research Future Fund; HTA: health technology assessment; MSAC: Medical Services Advisory Committee; WES: whole exome sequencing; WGS: whole genome sequencing.